Clover Health: Difference between revisions

Line 63:

===Funding and IPO===

~~From 2015 to 2017, Clover Health ran a series of~~ [[~~venture capital~~]] ~~funding rounds, receiving funding from~~ [[First Round Capital]], [[Sequoia Capital]], ~~and~~ Greenoaks ~~Capital. A~~ [[Series D]] ~~funding round in 2017 included support from~~ [[Alphabet Inc]]~~'s investment company~~ [[GV (company)|GV]] ~~and led to Clover Health being valued at more than $1.2 billion and achieving “~~[[Unicorn (finance)|unicorn]]~~” status.~~

2015年から2017年にかけて、Clover Healthは一連の[[:ja:ベンチャーキャピタル|ベンチャーキャピタル]]による資金調達ラウンドを実施し、[[Wikipedia:First Round Capital|First Round Capital]], [[Wikipedia:Sequoia Capital|Sequoia Capital]], Greenoaks Capitalから資金提供を受けた。2017年の[[:en:Series D|シリーズD]]資金調達ラウンドでは、[[Alphabet Inc]]の投資会社[[:en:GV (company)|GV]]からの支援も受け、Clover Healthは12億ドル以上の評価を受け、“[[:en:Unicorn (finance)|unicorn]]”の地位を獲得した。

~~In October 2020, the company announced that it had reached a $3.7 billion deal with~~ [[Chamath Palihapitiya~~]] and would [[Initial public offering~~|~~go public~~]] ~~through a merger with a~~ [[special-purpose acquisition company]]~~. Clover Health began trading on the NASDAQ under the ticker CLOV on January 8, 2021. The company ended its first day on the~~ public ~~market with a value of about $7 billion.~~

2020年10月、同社は[[Wikipedia:Chamath Palihapitiya|Chamath Palihapitiya]]と37億ドルの取引に合意し、[[:en:special-purpose acquisition company|特別目的買収会社]]との合併により[[:en:Initial public offering|株式公開]]すると発表した。Clover Healthは2021年1月8日にCLOVというティッカーでNASDAQでの取引を開始した。同社は公開初日を約70億ドルで終えた。

===Short seller report and "meme stock" status===

@@ Line 63: / Line 63: @@
 ===Funding and IPO===
-From 2015 to 2017, Clover Health ran a series of [[venture capital]] funding rounds, receiving funding from [[First Round Capital]], [[Sequoia Capital]], and Greenoaks Capital. A [[Series D]] funding round in 2017 included support from [[Alphabet Inc]]'s investment company [[GV (company)|GV]] and led to Clover Health being valued at more than $1.2 billion and achieving “[[Unicorn (finance)|unicorn]]” status.
+年から2017年にかけて、Clover Healthは一連の[[:ja:ベンチャーキャピタル|ベンチャーキャピタル]]による資金調達ラウンドを実施し、[[Wikipedia:First Round Capital|First Round Capital]], [[Wikipedia:Sequoia Capital|Sequoia Capital]], Greenoaks Capitalから資金提供を受けた。2017年の[[:en:Series D|シリーズD]]資金調達ラウンドでは、[[Alphabet Inc]]の投資会社[[:en:GV (company)|GV]]からの支援も受け、Clover Healthは12億ドル以上の評価を受け、“[[:en:Unicorn (finance)|unicorn]]”の地位を獲得した。
-In October 2020, the company announced that it had reached a $3.7 billion deal with [[Chamath Palihapitiya]] and would [[Initial public offering|go public]] through a merger with a [[special-purpose acquisition company]]. Clover Health began trading on the NASDAQ under the ticker CLOV on January 8, 2021. The company ended its first day on the public market with a value of about $7 billion.
+年10月、同社は[[Wikipedia:Chamath Palihapitiya|Chamath Palihapitiya]]と37億ドルの取引に合意し、[[:en:special-purpose acquisition company|特別目的買収会社]]との合併により[[:en:Initial public offering|株式公開]]すると発表した。Clover Healthは2021年1月8日にCLOVというティッカーでNASDAQでの取引を開始した。同社は公開初日を約70億ドルで終えた。
 ===Short seller report and "meme stock" status===